Abrilada® ,
Adalimumab-afzb
Disease
Crohn's disease
,
Ulcerative colitis
,
Drug Class
Biologics
Delivery Method
Injection
or
Brand name:
Abrilada®
(This drug is a biosimilar to Humira®)
,Drug name:
Adalimumab-afzb
Drug type
Anti-TNF
Recommendations for pregnancy
Effects to fetus are unknown
Recommendations for breastfeeding
Present in breast milk; talk to your doctor
Most common side effects
Common side-effects include injection site reactions such as redness, rash, swelling itching, pain or bruising; upper respiratory infections (including sinus infections); headaches, rash, and nausea
Other
Serious infections have included tuberculosis (TB) and other infections such as viruses, fungi, or bacteria that have spread throughout the body. For children and adults, the chance of getting lymphoma and other cancers may increase. Abrilada® is not yet available in the US market.
Learn more about
Biologics